Merck Global Health Innovation Fund (MGHIF) is a growth investor in digital health and data science companies, aiming to enhance biopharmaceutical operations and patient care. Founded in 2010, the fund manages over $600M and has made 60+ investments, focusing on early to growth-stage technologies in drug discovery, clinical development, manufacturing, supply chain, IT, and patient support.
Recent Transactions involving Merck Global Health Innovation Fund
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN |
M2GEN |
Clayton, Dubilier & RiceMerck Global Health Innovation FundMcKesson Ventures |
Health Informatics |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →